Log in to save to my catalogue

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_259613

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

About this item

Full title

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2017-11, Vol.377 (18), p.1723-1732

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

In this phase 3 trial, among infants with spinal muscular atrophy, those who received nusinersen were more likely to achieve major motor milestones and less likely to need permanent assisted ventilation than those who underwent a sham procedure.

Alternative Titles

Full title

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_gup_ub_gu_se_259613

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_259613

Other Identifiers

ISSN

0028-4793,1533-4406

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1702752

How to access this item